8th International Symposium on Growth and Nutrition in Children with Chronic Renal Disease: 28-30 May 2009, Oviedo, Asturias, Spain.

摘要

In spite of the numerous advances made over the last few decades in the management of children with chronic renal disease, including optimization of nutrition, administration of recombinant human growth hormone (GH), control of anemia and bone disease, prevention of infections and the rational surgical approach to congenital nephrourologic malformations, growth retardation is still a major clinical manifestation of pediatric patients with chronic kidney failure or primary tubular disorders. Achievement of a subnormal final height is an important invaliding sequela that makes the adequate social integration of adults with chronic diseases difficult. Children with chronic nephrop-athies characteristically do not reach their genetic potential in height, even if their final stature is within the normal reference ranges. Minimizing the loss of height in children with chronic diseases remains a major challenge for pediatricians who deal with these patients.